Expresión de TLR2, 4, 9 y presencia de células tipo NK CD56 positivas en lesiones de pacientes con diferentes formas de clínicas de leismaniasis cutánea americana
Resumen
Palabras clave
Texto completo:
PDFReferencias
Abou Fakher F. H., Rachinel N., Klimczak M., Louis J. & Doyen N. (2009). TLR9-Dependent Activation
of Dendritic Cells by DNA from Leishmania major Favors Th1 Cell Development and the Resolution
of Lesions. J. Immunol. 183: 1386-1396.
Bajénoff M., Breart B., Huang A. Y., Qi H., Cazareth J., Braud V. M., et al. (2006). Natural killer cell
behavior in lymph nodes revealed by static and real-time imaging. J. Exp. Med. 203: 619-631.
Bacellar O., Faria D., Nascimento M., Cardoso T. M., Gollob K. J., Dutra W. O., et al. (2009). Interleukin
production among patients with American cutaneous leishmaniasis. J. Infect. Dis. 200: 75-78.
Becker I., Salaiza N., Aguirre M., Delgado J., Carrillo-Carrasco N., Gutiérrez Kobeh L., et al. (2003). Leishmania lipophosphoglycan (LPG) activates NK cellsthroughtoll-like receptor-2. Mol. Bioch. Parasitol. 130: 65–74.
Boaventura V. S., Santos C. S., Cardoso C. R., de Andrade J., Dos Santos W. L., Clarêncio J., et al.,(2010). Human mucosal leishmaniasis: neutrophils infiltrate areas of tissue damage that express high levels of Th17-related cytokines. Eur. J. Immunol. 40: 2830-2836.
Caceres-Dittmar G., Tapia F. J., Sanchez M. A., Yamamura M., Uyemura K., Modlin R. L., et al. (1993). Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clin. Exp. Immunol. 91: 500-505.
Convit J. & Pinardi M. E. (1974). Cutaneous leishmaniasis. The clinical and immunopathological spectrum in South America. p.159-166. En: Trypanosomiasis and leismaniasis with special reference to
Chagas disease. Ciba Foundation Symposium 20. Elsevier Excerp Med. Amsterdam, North Holland.
Convit J., Ulrich M., Fernández C. T., Tapia F. J., Cáceres-Dittmar G., Castés M., et al. (1993). The clinical and immunological spectrum of American cutaneous leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 87: 444-448.
de Lima H., Borges R. H., Escobar J. & Convit J. (2011). Leishmaniasis cutánea americana en Venezuela, bienio 2008-2009. Bol. Mal. Salud Amb. 51: 215-224.
De Veer M. J., Curtis J. M., Baldwin T. M., DiDonato J. A., Sexton A., McConville M. J., et al. (2003).
MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling. Eur. J. Immunol. 33: 2822-2831.
Díaz N. L., Arveláez F. A., Zerpa O. &, Tapia F. J. (2006). Inducible nitric oxide synthase and cytokine pattern in lesions of patients with American cutaneous leishmaniasis. Clin. Exp. Dermatol. 31: 114-117.
Díaz N. L., Zerpa O., Ponce L. V., Convit J., Rondon A. J. & Tapia F. J. (2002). Intermadiate or chronic cutaneous leishmaniasis: Leukocyte immunophenotypes and cytokine characterization of lesion. Exp. Dermatol. 11:34-41.
Gazzinelli R. T. & Denkers E. Y. (2006). Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism. Nat. Rev. Immunol. 6: 895-906.
Hari A., Flach T. L., Shi Y. & Mydlarski P. R. (2010). Toll-like receptors: role in dermatological disease. Mediators Inflamm. 437246. doi: 10.1155/2010/437246.
Katara G. K., Ansari N. A., Singh A., Ramesh V. & Salotra P. (2012). Evidence for involvement of Th17 type responses in post kala azar dermal leishmaniasis (PKDL). PLoS Negl. Trop. Dis. 6: e1703.
Kiyoshi T. & Shizuo A. (2005). Toll-like receptors in innate immunity. Inter. Immunol. 17: 1–14.
Kropf P., Freudenberg M. A., Modolell M., Price H. P., Herath S., Antoniazi S., et al. (2004). TollLike receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major. Infect. Immun. 72: 1920–1928.
Laurenti M. D., Gidlund M., Ura D. M., Sinhorini I. L., Corbett C. E & Goto H. (1999). The role of natural killer cells in the early period of infection in murine cutaneous leishmaniasis. Braz. J. Med. Biol. Res. 32: 323–325.
Lieke T., Nylén S., Eidsmo L., McMaster W. R., Mohammadi A. M., Khamesipour A., et al. (2008) Leishmania surface protein gp63 binds directly to human natural killer cells and inhibits proliferation. Clin. Exp. Immunol. 153: 221-230.
Maasho K., Sanchez F., Schurr E., Hailu A. & Akuffo H. (1998). Indications of the protective role of natural killer cells in human cutaneous leishmaniasis in an area of endemicity. Infect. Immun. 66: 2698-2704.
Martínez-Salazar B., Berzunza-Cruz M. & Becker I. (2008). Leishmania mexicana DNA activates
murine macrophages and increases their TLR9 expression. Gac. Med. Mex. 144: 99-104.
Prajeeth C.K., Haeberlein S., Sebald H., Schleicher U. & Bogdan C.(2011). Leishmania-infected macrophages are targets of NK cell-derived cytokines, but not of NK cell cytotoxicity. Infect. Immun. 79: 2699-2708.
Sanabria M. X., Vargas-Inchaustegui D. A., Xin L. & Soong L. (2008). Role of natural killer cells in modulating dendritic cell responses to Leishmania amazonensis infection. Infect. Immun. 76: 5100-5109.
Scharton T.M., & Scott P. (1993). Natural killer cells are a source of IFN-γ that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178: 567–578.
Tuon F. F., Fernandes E. R., Duarte M.I . & Amato V. S. (2012). Expression of TLR2 and TLR4 in lesions of patients with tegumentary American leishmaniasis. Rev. Inst. Med. Trop. Sao Paulo. 54: 159-63.
Tuon F. F., Fernandes E. R, Pagliari C., Duarte M. I. & Amato V. S. (2010). The expression of TLR9 in human cutaneous leishmaniasis is associated with granuloma. Parasite Immunol. 32: 769-772.
Whitaker S. M., Colmenares M., Pestana K. G. & Mc Mahon-Pratt D. (2008). Leishmania pifanoi proteoglycolipid complex P8 induces macrophage cytokine production through Toll-like receptor 4. Infect. Immun. 76: 2149-2156
WHO (2010). Control of the leishmaniases. Report of a meeting of the WHO Expert Committee on the
control of the leishmaniasis. Techn. Report Series Nº 949. Geneva, Switzerland.
Enlaces refback
- No hay ningún enlace refback.
Copyright (c) 2021 Boletín de Malariología y Salud Ambiental